IQVIA Holdings (FRA:QTS) Inventories, Raw Materials & Components: €0 Mil (As of Mar. 2026)


FRA:QTS IQVIA Holdings Inc FRA:QTS
90 GF Score
Price €168.75
GF Value €217.43
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is IQVIA Holdings Inventories, Raw Materials & Components?

IQVIA Holdings FRA:QTS +1.14% 90 Inventories, Raw Materials & Components is €0 Mil as of Mar. 2026. GuruFocus rates FRA:QTS with a GF Score™ of 90/100 and a GF Value™ of €217.43 (Modestly Undervalued). The stock has 3 warning signs investors should review.

IQVIA Holdings's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €0 Mil.

IQVIA Holdings Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Inventories, Raw Materials & Components Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IQVIA Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:QTS
90GF Score
IQVIA Holdings Inc FRA:QTS
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0 Mil mean?
IQVIA Holdings (FRA:QTS) has a Inventories, Raw Materials & Components of €0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Inventories, Raw Materials & Components too high?
IQVIA Holdings' current Inventories, Raw Materials & Components is €0 Mil. Overall, IQVIA Holdings has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Inventories, Raw Materials & Components compare to WAT and ILMN?
IQVIA Holdings' Inventories, Raw Materials & Components of €0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Inventories, Raw Materials & Components is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (FRA:QTS) is currently considered Modestly Undervalued. The stock's GF Value™ is €217.43, compared to a current price of €168.75 — trading 22.4% below its estimated fair value. The current Inventories, Raw Materials & Components is €0 Mil. IQVIA Holdings' overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For IQVIA Holdings (FRA:QTS), the current Inventories, Raw Materials & Components is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (FRA:QTS) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €168.75 is trading 22.4% below its estimated GF Value™ of €217.43. GuruFocus considers IQVIA Holdings to be Modestly Undervalued.

Key valuation signals for FRA:QTS:

  • Inventories, Raw Materials & Components: €0 Mil
  • GF Value™: €217.43 vs. price of €168.75 (22.4% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the FRA:QTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
90GF Score

Get the complete analysis for FRA:QTS

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€168.75
Price
€217.43
GF Value